Table 1.
Patient clinicopathologic characteristics.
| Value | ||
|---|---|---|
| Age (years) | Median (range) | 60 (19-83) |
| cTNM | II/III | 45/61 |
| Pathology | Adenocarcinoma/mucinous | 101/5 |
| ypT | 0/1/2/3/4 | 24/5/46/29/2 |
| ypN | 0/1/2 | 80/18/8 |
| pCR | Yes/no | 23/83 |
| ypTNM | 0/I/II/III/IV | 23/40/17/26/0 |
| CEA | Median (range) | 3.20 (0.50-172.92) |
| CA19-9 | Median (range) | 11.40 (1.20-1022.50) |
| Pre-CRT Fib (mg/dl) | Median (range) | 3.45 (0.50-6.84) |
| Post-CRT Fib (mg/dl) | Median (range) | 3.37 (1.85-7.67) |
| Pre-CRT Alb (g/l) | Median (range) | 40.35 (27.0-50.20) |
| Post-CRT Alb (g/l) | Median (range) | 40.40 (23.4-51.90) |
| Pre-CRT FA score | 0/1/2 | 85/16/5 |
| Post-CRT FA score | 0/1/2 | 75/24/7 |
pCR: pathologic complete response; CEA: carcinoembryonic antigen; CA19-9: carbohydrate antigen 19-9; CRT: chemoradiotherapy; Fib: fibrinogen; Alb: albumin; FA: fibrinogen and albumin.